Is Ozempic (Semaglutide) Right For Me?

Obesity is the leading preventable cause of death, with about a third of North Americans classified as obese. One of the few effective treatments was bariatric surgery. Health Canada recently approved a new weight loss drug, semaglutide, also known by the brand names “Ozempic” or “Wegovy.” Experts refer to it as a “game changer” for its ability to curtail appetite and spur weight loss.

In this episode, Medcan’s director of weight management, Dr. David Macklin, a co-author of Canada’s national guidelines for obesity treatment, provides host Shaun Francis with a Ozempic (semaglutide) explainer. “We’re in a super exciting stage in my field of medicine,” Dr. Macklin says. “I can safely say that 2022, for a number of reasons, will be characterized in history as the first time that we have a very effective non-surgical treatment for [obesity].”

For complete episode links and time-coded insights, visit the Eat Move Think episode 115 web page at the following: eatmovethinkpodcast.com/podcast/ep115-is-semaglutide-right-for-me

• #education
• #medcan
• #eat_move_think
• #emt_ep_115_is_ozempic_semaglutide_right_for_me
• #eat_move_think_podcast
• #eat_move_think_ep_115_podcast
• #medcan_podcast
• #medcan_emt
• #is_semaglutide_right_for_me
• #what_is_semaglutide
• #semaglutide
• #semaglutide_type_2_diabetes
• #semaglutide_weight_loss
• #how_does_semaglutide_help_with_weight_loss
• #best_weight_loss_drugs
• #best_weight_loss_supplements
• #semaglutide_weight_loss_medication
• #best_weight_loss_medication
• #semaglutide_fat_loss
• #is_ozempic_right_for_me